Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel O’Shea
Anti-Tumour Activity of a First-In-Class Agent NUC-1031 in Patients With Advanced Cancer: Results of a Phase I Study
British Journal of Cancer
Cancer Research
Oncology
Related publications
A Phase I First-In-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I Study of Temozolomide in Paediatric Patients With Advanced Cancer
British Journal of Cancer
Cancer Research
Oncology
Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Phase I Study of Indoximod in Patients With Advanced Malignancies
Oncotarget
Oncology
Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors
Cancer Science
Cancer Research
Medicine
Oncology
Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Phase I First-In-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients With Advanced Cancer
Clinical Cancer Research
Cancer Research
Oncology
